ANDA 215035, held by Amneal. Amlodipine Benzoate.
As of Nov 16, 2026, ANDA 215035 (Amlodipine Benzoate), held by Amneal, was first approved by FDA on Jun 13, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 13, 2023 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amlodipine BenzoateEQ 1MG BASE/ML ยท suspension;oral | Amlodipine Benzoate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters